SeraNovo

SeraNovo has a rich technical platform in formulation development, which can enhance intestinal solubility and drug bioavailability. SeraNovo specializes in the development of oral formulations for poorly soluble drugs and has invented the Deep Eutectic Solvent platform technology, signing its first licensing agreement in October 2019.